tradingkey.logo

BofA downgrades Centene as new bill threatens Medicaid and ACA growth

ReutersJul 16, 2025 11:57 AM

BofA Global Research downgrades health insurer Centene CNC.N to "underperform" from "neutral", trims PT to $30 from $52

Medicaid and Affordable Care Act (ACA) exchange markets are slowing due to the new Reconciliation Bill, and there's a strong chance that enhanced government subsidies for ACA coverage will expire after 2025, BofA analysts say

Brokerage expects at least $2.75 per share of pressure from the ACA exchanges, plus higher costs in Medicaid

Membership declines driven by the new legislation are expected to slow CNC’s revenue growth through 2029, while shifting insurance risks and potential Medicaid rate cuts will make it more difficult for the company to restore normal profit margins, BofA analysts say

As of last close, CNC stock down 50.5% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI